Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Ophthalmology

Life After Treatment: Your Long-Term Vision Outlook

At a Glance

After hydroxychloroquine or chloroquine is stopped, retinal damage may stabilize if caught early, but established damage can progress for months or years. Regular eye monitoring and early low-vision support help protect safety, independence, and quality of life.

Stopping hydroxychloroquine or chloroquine is the most important step in protecting your eyes, but it is not the end of your journey. Because these medications are stored in the body for a long time, the retina requires ongoing care and monitoring even after the drug is out of your system [1][2].

Understanding your long-term prognosis depends heavily on how early the toxicity was caught. While some patients find stability, others must learn to navigate life with permanent changes to their vision.

Will the Damage Stop Getting Worse?

The answer depends on the stage of the disease at the time you stopped the medication. Progression after stopping varies substantially based on the extent and location of the damage.

  • Early-Stage Toxicity: If the damage was caught before there was visible injury to the retinal pigment epithelium (RPE), the prognosis is often positive. While not guaranteed, early abnormalities frequently stabilize over time after stopping the drug [3][4].
  • Moderate to Severe Toxicity: If the RPE layer was already damaged or if the fovea (the center of the eye) was involved, the disease often continues to progress [3]. Because the medication clears slowly, the retina can continue to thin and blind spots can expand for months to years, and in rare severe cases, progressive damage has been reported for up to two decades after cessation [5][2].

(Note: Monitoring trends over time is much more informative than focusing on a specific timeline or deadline for stability.)

The Need for Continued Monitoring

You might expect that once the drug is stopped, you no longer need specialized eye exams. However, because of the risk of long-term progression, individualized long-term ophthalmic monitoring is essential [1].

Your care team will continue to use tools like SD-OCT (structural scans), FAF, and Visual Fields to track the health of your retina [1][6]. These follow-ups help your doctor determine if your retinas have stabilized or if new areas are at risk. (Reminder: If you ever experience a sudden dark shadow, flashes of light, or sudden vision loss, do not wait for your scheduled screening—seek same-day emergency care).

Living with Vision Loss

If you have experienced significant vision loss, there are many tools and strategies available to help you maintain your independence and quality of life. Do not wait until your vision is severely impaired to seek these resources.

Low-Vision Rehabilitation

A referral to a low-vision specialist (often an optometrist or ophthalmologist) can be life-changing [7]. They may recommend:

  • Magnification Tools: High-powered reading glasses, hand-held magnifiers, or electronic “video” magnifiers.
  • Electronic Reading Aids: For those with central blind spots, software that scrolls text horizontally (like a news ticker) can sometimes be easier to follow [8].
  • Lighting and Contrast: Optimizing the light in your home and using high-contrast markers (like black tape on white stairs) can significantly improve safety and mobility [9].

Additional Support Services

Beyond magnification, consider asking your doctor for referrals to:

  • Occupational Therapy: To help you adapt daily tasks (cooking, managing medications) to your current vision level.
  • Orientation and Mobility Services: Specialized training to help you safely navigate your home, neighborhood, and public transit, reducing the risk of falls.
  • Driving Counseling: Honest, supportive evaluations regarding your safety behind the wheel.

Navigating the Emotional Impact

Irreversible vision loss is an emotional challenge. Many patients report feelings of frustration, loss of independence, or social isolation [7]. You do not have to face these changes alone. Many organizations offer support groups and counseling for people with macular disease, helping you find community and new ways to engage with the world.

Common questions in this guide

Can antimalarial retinal damage keep getting worse after I stop the medication?
Not always. When toxicity is found before visible retinal pigment epithelium damage, retinal changes often stabilize after the drug is stopped. If the retinal pigment epithelium or fovea is already damaged, thinning and blind spots may continue to worsen for months or years, so ongoing monitoring is important.
How does retinal pigment epithelium or foveal damage affect my outlook?
Damage to the retinal pigment epithelium or fovea generally indicates more advanced retinal injury and a greater chance that changes will continue after hydroxychloroquine or chloroquine is stopped. Your ophthalmologist can assess the location and extent of damage using your scans and visual field results.
Why do I need eye exams after stopping hydroxychloroquine or chloroquine?
These medicines can remain in the body for a long time, and retinal damage may continue even after treatment stops. Follow-up exams help your eye doctor determine whether the retina is stable or whether blind spots and thinning are changing.
Which tests are used to monitor antimalarial toxic maculopathy?
Doctors commonly use structural optical coherence tomography scans, fundus autofluorescence imaging, and visual field testing. Comparing results over time helps show whether retinal damage is stable or progressing.
What support can help if antimalarial toxicity has caused vision loss?
A low-vision specialist can recommend magnifiers, electronic reading aids, better lighting, and high-contrast changes. Occupational therapy, orientation and mobility training, driving counseling, and emotional support may also help you remain safe and independent.
Which vision changes require urgent medical attention?
Seek same-day emergency eye care for a sudden dark shadow, flashes of light, or sudden vision loss. Do not wait for your next scheduled screening if one of these symptoms occurs.

Get notified when new evidence is published on Toxic maculopathy due to antimalarial drugs.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    The Relationship of Hydroxychloroquine Retinopathy Progression to Stage at Cessation of Therapy.

    Browning DJ, Koonce DR, Mentreddy A, Punjabi O

    American journal of ophthalmology 2025; (277()):335-348 doi:10.1016/j.ajo.2025.05.030.

    PMID: 40447243
  2. 2

    Delayed progression of bull's eye maculopathy.

    Jain S, Jain NG

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2017-220598.

    PMID: 28596207
  3. 3

    Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.

    Ahn SJ, Seo EJ, Kim KE, et al.

    Ophthalmology 2021; (128(6)):889-898 doi:10.1016/j.ophtha.2020.10.029.

    PMID: 33129843
  4. 4

    Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.

    de Sisternes L, Hu J, Rubin DL, Marmor MF

    Investigative ophthalmology & visual science 2015; (56(5)):3415-26 doi:10.1167/iovs.14-16345.

    PMID: 26024126
  5. 5

    SEQUENTIAL CHANGES IN HYDROXYCHLOROQUINE RETINOPATHY UP TO 20 YEARS AFTER STOPPING THE DRUG: Implications for Mild Versus Severe Toxicity.

    Pham BH, Marmor MF

    Retina (Philadelphia, Pa.) 2019; (39(3)):492-501 doi:10.1097/IAE.0000000000002408.

    PMID: 30550532
  6. 6

    LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.

    Allahdina AM, Chen KG, Alvarez JA, et al.

    Retina (Philadelphia, Pa.) 2019; (39(3)):473-484 doi:10.1097/IAE.0000000000002437.

    PMID: 30741731
  7. 7

    Depression secondary to vision loss in old age and an effective rapid screening tool for undiagnosed cases.

    Clancy N, Aslam T, Cackett P

    Annals of general psychiatry 2022; (21(1)):15 doi:10.1186/s12991-022-00396-0.

    PMID: 35655227
  8. 8

    A comparison of reading, in people with simulated and actual central vision loss, with static text, horizontally scrolling text, and rapid serial visual presentation.

    Akthar F, Harvey H, Subramanian A, et al.

    Journal of vision 2021; (21(12)):5 doi:10.1167/jov.21.12.5.

    PMID: 34751737
  9. 9

    Reading in the presence of macular disease: a mini-review.

    Chung STL

    Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) 2020; (40(2)):171-186 doi:10.1111/opo.12664.

    PMID: 31925832

This page is for informational purposes only and does not constitute medical advice. Your ophthalmologist or low-vision specialist can interpret your scans, prognosis, and support needs.